Skip to content
Clinical Trials – home

Colorectal cancer metastatic Trials in Disease

Clinical trials for Colorectal cancer metastatic

Recruiting trials first

See all 105 trials →
Quick filters

105 clinical trials in this condition

Countries:AustriaAustria
  • Participants:18–64 years
  • Substances:Bevacizumab
  • Sponsor:Amgen Inc.
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:Summit Therapeutics Inc.
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:Seagen Inc.
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Glatiramer Acetate
  • Sponsor:Genmab A/S
See all 105 trials →filters applied: condition = Colorectal cancer metastatic

In short

Metastatic colorectal cancer is a serious condition where cancer spreads from the colon or rectum to other parts of the body. Currently, 80 clinical trials are investigating new treatments and treatment combinations for patients with this disease. These studies are exploring various approaches including chemotherapy combinations, immunotherapy, targeted therapies, and novel experimental treatments to improve outcomes for patients whose cancer has spread beyond its original location.

# Clinical Trials for Metastatic Colorectal Cancer

Clinical trial locations

This guide is here to help you understand the condition. It does not replace a conversation with your doctor, who knows your situation best.

Related conditions in the same therapeutic area

Back to all diseases
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.